749 related articles for article (PubMed ID: 27116248)
1. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.
Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H
Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248
[TBL] [Abstract][Full Text] [Related]
2. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of AA amyloidosis patients in San Francisco.
Lejmi H; Jen KY; Olson JL; James SH; Sam R
Nephrology (Carlton); 2016 Apr; 21(4):308-13. PubMed ID: 26370715
[TBL] [Abstract][Full Text] [Related]
4. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.
Decourt A; Gondouin B; Delaroziere JC; Brunet P; Sallée M; Burtey S; Dussol B; Ivanov V; Costello R; Couchoud C; Jourde-Chiche N
Clin J Am Soc Nephrol; 2016 Mar; 11(3):431-41. PubMed ID: 26728585
[TBL] [Abstract][Full Text] [Related]
5. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis.
Kuroda T; Tanabe N; Hasegawa E; Wakamatsu A; Nozawa Y; Sato H; Nakatsue T; Wada Y; Ito Y; Imai N; Ueno M; Nakano M; Narita I
Amyloid; 2017 Jun; 24(2):123-130. PubMed ID: 28613962
[TBL] [Abstract][Full Text] [Related]
6. Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement.
Badar T; Cornelison AM; Shah ND; Bashir Q; Parmar S; Patel K; Hosing C; Popat U; Weber DM; Thomas SK; Shah JJ; Orlowski RZ; Champlin RE; Qazilbash MH
Eur J Haematol; 2016 Oct; 97(4):342-7. PubMed ID: 26773409
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes and survival in AA amyloidosis patients.
Ayar Y; Ersoy A; Oksuz MF; Ocakoglu G; Vuruskan BA; Yildiz A; Isiktas E; Oruc A; Celikci S; Arslan I; Sahin AB; Güllülü M
Rev Bras Reumatol Engl Ed; 2017; 57(6):535-544. PubMed ID: 29173691
[TBL] [Abstract][Full Text] [Related]
8. Remission of proteinuria and preservation of renal function in patients with renal AA amyloidosis secondary to rheumatoid arthritis.
Ueno T; Takeda K; Nagata M
Nephrol Dial Transplant; 2012 Feb; 27(2):633-9. PubMed ID: 21771754
[TBL] [Abstract][Full Text] [Related]
9. Association between clinical characteristics and AL amyloid deposition in the kidney.
Itabashi M; Takei T; Tsukada M; Sugiura H; Uchida K; Tsuchiya K; Honda K; Nitta K
Heart Vessels; 2010 Nov; 25(6):543-8. PubMed ID: 20922533
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.
Gertz MA; Leung N; Lacy MQ; Dispenzieri A; Zeldenrust SR; Hayman SR; Buadi FK; Dingli D; Greipp PR; Kumar SK; Lust JA; Rajkumar SV; Russell SJ; Witzig TE
Nephrol Dial Transplant; 2009 Oct; 24(10):3132-7. PubMed ID: 19403931
[TBL] [Abstract][Full Text] [Related]
11. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution.
Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N
Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754
[TBL] [Abstract][Full Text] [Related]
12. Clinical and laboratory profile of renal amyloidosis: A single-center experience.
Engineer DP; Kute VB; Patel HV; Shah PR
Saudi J Kidney Dis Transpl; 2018; 29(5):1065-1072. PubMed ID: 30381502
[TBL] [Abstract][Full Text] [Related]
13. Renal involvement in AA amyloidosis: clinical outcomes and survival.
Yilmaz M; Unsal A; Sokmen M; Kaptanogullari OH; Alkim C; Kabukcuoglu F; Ozagari A; Bor E
Kidney Blood Press Res; 2013; 37(1):33-42. PubMed ID: 23548761
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for renal amyloidosis: a clinicopathological study using cluster analysis.
Sasatomi Y; Sato H; Chiba Y; Abe Y; Takeda S; Ogahara S; Murata T; Kaneoka H; Takebayashi S; Iwasaki H; Saito T
Intern Med; 2007; 46(5):213-9. PubMed ID: 17329915
[TBL] [Abstract][Full Text] [Related]
15. Kidney biopsy in AA amyloidosis: impact of histopathology on prognosis.
Kendi Celebi Z; Kiremitci S; Ozturk B; Akturk S; Erdogmus S; Duman N; Ates K; Erturk S; Nergizoglu G; Kutlay S; Sengul S; Ensari A; Keven K
Amyloid; 2017 Sep; 24(3):176-182. PubMed ID: 28686525
[TBL] [Abstract][Full Text] [Related]
16. A clinicopathological analysis in a large cohort of Chinese patients with renal amyloid light-chain amyloidosis.
Yao Y; Wang SX; Zhang YK; Qu Z; Liu G; Zou WZ
Nephrol Dial Transplant; 2013 Mar; 28(3):689-97. PubMed ID: 23182813
[TBL] [Abstract][Full Text] [Related]
17. LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis.
Boynton SJ; Geske JB; Dispenzieri A; Syed IS; Hanson TJ; Grogan M; Araoz PA
JACC Cardiovasc Imaging; 2016 Jun; 9(6):680-6. PubMed ID: 27209101
[TBL] [Abstract][Full Text] [Related]
18. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response.
Verine J; Mourad N; Desseaux K; Vanhille P; Noël LH; Beaufils H; Grateau G; Janin A; Droz D
Hum Pathol; 2007 Dec; 38(12):1798-809. PubMed ID: 17714761
[TBL] [Abstract][Full Text] [Related]
19. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
20. [Secondary amyloidosis (AA) and renal disease].
Torregrosa E; Hernández-Jaras J; Calvo C; Ríus A; García-Pérez H; Maduell F; Vera JM
Nefrologia; 2003; 23(4):321-6. PubMed ID: 14558331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
